¸¸¼ºÁúȯ °ü¸® ½ÃÀå : Ç÷§Æû À¯Çüº°, ¼­ºñ½º À¯Çüº°, Áúº´ À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Chronic Disease Management Market, By Platform Type, By Service Type, By Disease Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1574984
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 284 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,574,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,544,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,952,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸¸¼ºÁúȯ °ü¸® ½ÃÀå ±Ô¸ð´Â 2023³â 51¾ï 932¸¸ ´Þ·¯·Î 2024-2032³â CAGR 14.90%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¸¼ºÁúȯ °ü¸® ½ÃÀå - ½ÃÀå ¿ªÇÐ

¿¹¹æÀû ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå È®´ë°¡ °¡¼ÓÈ­

¿¹¹æÀû ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ Á¶±â °³ÀÔ°ú Áö¼ÓÀûÀÎ °ü¸®ÀÇ Á߿伺À» ÀνÄÇÏ´Â Á¶Á÷°ú Á¤ºÎ°¡ ´Ã¾î³ª¸é¼­ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå È®´ë¿¡ Å« ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)¿¡ µû¸£¸é, ¸¸¼ºÁúȯÀº ¹Ì±¹ ³» 10´ë »ç¸Á¿øÀÎ Áß 7°³¸¦ Â÷ÁöÇϰí ÀÖ¾î È¿°úÀûÀÎ °ü¸® Àü·«ÀÇ ½Ã±Þ¼ºÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ±¹¸³º¸°Ç¿ø(National Institute of Health)ÀÇ ¿¬±¸¿¡ µû¸£¸é, »ýȰ½À°ü °³¼±°ú ¿¹¹æ Á¶Ä¡¸¦ ÅëÇØ ¸¸¼ºÁúȯ ¹ßº´ À§ÇèÀ» 80%±îÁö ³·Ãâ ¼ö ÀÖ´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ, ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ¼¼°è Çൿ °èȹ(Global Action Plan)°ú °°Àº ÀÌ´Ï¼ÅÆ¼ºê´Â 2025³â±îÁö ºñ°¨¿°¼º ÁúȯÀ¸·Î ÀÎÇÑ Á¶±â »ç¸Á·üÀ» 25% °¨¼Ò½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖÀ¸¸ç, ¿¹¹æ¿¡ ÃÊÁ¡À» ¸ÂÃá Á¾ÇÕÀûÀÎ ¸¸¼ºÁúȯ °ü¸® ÇÁ·Î±×·¥ÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯ °ü¸® ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¿¬±¸ ºÐ¼®°¡µéÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032) µ¿¾È ¾à 14.90%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ç÷§Æû À¯Çüº°·Î´Â Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.

¼­ºñ½º À¯Çüº°·Î´Â Äɾî ÄÚµð³×À̼ÇÀÌ 2023³â ÁÖ¿ä À¯ÇüÀÔ´Ï´Ù.

Áúº´ À¯Çüº°·Î´Â 2023³â ½ÉÇ÷°üÁúȯÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î ºÎ»óÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â¿¡ ¼öÀÍÀ» âÃâÇÏ´Â ÁÖ¿ä ½ÃÀåÀ¸·Î ²ÅÇû½À´Ï´Ù.

¸¸¼ºÁúȯ °ü¸® ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

¼¼°è ¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀº Ç÷§Æû À¯Çü, ¼­ºñ½º À¯Çü, Áúº´ À¯Çü, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

Ç÷§Æû À¯Çü¿¡ µû¶ó ½ÃÀåÀº À¥ ±â¹Ý ¼Ö·ç¼Ç, Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç, ¿ÂÇÁ·¹¹Ì½º ¼Ö·ç¼ÇÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀº È®À强°ú Á¢±Ù¼ºÀ¸·Î ÀÎÇØ ÀαⰡ ³ôÀ¸¸ç, À¥ ±â¹Ý ¼Ö·ç¼ÇÀº ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô »ç¿ëÇϱ⠽¬¿î ÀÎÅÍÆäÀ̽º¸¦ Á¦°øÇÏ´Â À¥ ±â¹Ý ¼Ö·ç¼ÇÀÌ ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù. ¿ÂÇÁ·¹¹Ì½º ¼Ö·ç¼ÇÀº ÁÖ·Î µ¥ÀÌÅÍ º¸¾ÈÀ» À§ÇØ ´ë±Ô¸ð ÀÇ·á ±â°ü¿¡¼­ »ç¿ëµÇ¸ç, 3À§¸¦ Â÷ÁöÇß½À´Ï´Ù.

½ÃÀåÀº ¼­ºñ½º À¯Çü¿¡ µû¶ó ÄÁ¼³ÆÃ, Äɾî ÄÚµð³×À̼Ç, ±³À° ¹× ÈÆ·Ã, ¸ð´ÏÅ͸µ ¹× Æò°¡ µî 4°¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Äɾî ÄÚµð³×ÀÌ¼Ç ¼­ºñ½º´Â ȯÀÚ °ü¸®¿¡¼­ Áß¿äÇÑ ¿ªÇÒ·Î ¿ì¼±¼øÀ§¸¦ Â÷ÁöÇϸç, Áö¼ÓÀûÀÎ Æò°¡¸¦ º¸ÀåÇÏ´Â ¸ð´ÏÅ͸µ ¹× Æò°¡ ¼­ºñ½º°¡ ±× µÚ¸¦ ÀÕ½À´Ï´Ù. ÄÁ¼³ÆÃÀº 3À§¸¦ Â÷ÁöÇßÀ¸¸ç, ±³À° ¹× ÈÆ·Ã ¼­ºñ½º´Â ȯÀÚ ¿ª·® Çâ»ó¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¸¸¼ºÁúȯ °ü¸® ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀº ´Ù¾çÇÑ Áö¿ªÀû ¿ªÇаü°è¸¦ º¸À̰í ÀÖÀ¸¸ç, ±× Áß ºÏ¹Ì´Â ³ôÀº ÀÇ·áºñ ÁöÃâ°ú ³ôÀº ¼öÁØÀÇ ÀÎÇÁ¶ó¸¦ ¹ÙÅÁÀ¸·Î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â CDCÀÇ Àü±¹ ´ç´¢º´ ¿¹¹æ ÇÁ·Î±×·¥(CDC National Diabetes Prevention Program)°ú °°Àº ³ë·ÂÀ¸·Î Âü¿©ÀÚÀÇ ´ç´¢º´ ¹ßº´·üÀ» 58% °¨¼Ò½ÃÄ×À¸¸ç, µ¶Àϰú ¿µ±¹¿¡¼­´Â 100¸¸ ¸í ÀÌ»óÀÇ È¯ÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇÑ NHSÀÇ ´ç´¢º´ °ü¸® ÇÁ·Î±×·¥¿¡¼­ º¼ ¼ö ÀÖµíÀÌ ¸¸¼ºÁúȯÀ» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇÑ ÅëÇÕÀû Ä¡·á ¸ðµ¨À» ¿ì¼±½ÃÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀ» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇÑ ÅëÇÕÀû Ä¡·á ¸ðµ¨À» ¿ì¼±½ÃÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀνÄÀÇ Áõ°¡¿Í ³ëÀÎ Àα¸ÀÇ Áõ°¡¿¡ ÈûÀÔ¾î ºü¸£°Ô ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÀϺ» ÈÄ»ý¼ºÀº ¸¸¼ºÁúȯ ÅðÄ¡¸¦ À§ÇØ ºñ¸¸°ú ´ë»çÁõÈıºÀ» ´ë»óÀ¸·Î ÇÏ´Â µ¶ÀÚÀûÀÎ °Ç°­°ü¸® ÀÌ´Ï¼ÅÆ¼ºê¸¦ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼­´Â ºê¶óÁúÀÌ ¿¹¹æÀû °Ç°­°ü¸® ¸ðµ¨À» ÁöÇâÇÏ¸ç °íÇ÷¾Ð°ú ´ç´¢º´¿¡ ´ëóÇϱâ À§ÇÑ °øÁߺ¸°Ç Ä·ÆäÀο¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­´Â ¿ø°ÝÀÇ·á ¼­ºñ½º ¹× Áö¿ª ÀÇ·á ÇÁ·Î±×·¥À» ÅëÇØ ¸¸¼ºÁúȯ °ü¸®¸¦ °­È­Çϱâ À§ÇÑ ³ë·Â°ú ÇÔ²² ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯ °ü¸® ½ÃÀå - °æÀï ȯ°æ:

¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀÇ °æÀï ±¸µµ´Â ´Ù¾çÇÑ Áö¿ªÀÇ ÁÖ¿ä ±â¾÷µéÀÌ È¯ÀÚ °ü¸®¸¦ °­È­Çϱâ À§ÇØ Àû±ØÀûÀ¸·Î ³ë·ÂÇϰí ÀÖ´Â °¡¿îµ¥, °¢ Áö¿ªÀÇ ÁÖ¿ä ±â¾÷µéÀÌ °æÀï ±¸µµ¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¿©ÀüÈ÷ ¼±µÎ¸¦ ´Þ¸®°í ÀÖÀ¸¸ç, UnitedHealth Group ¹× Cigna¿Í °°Àº ±â¾÷ÀÌ ¸¸¼ºÁúȯ °ü¸®¸¦ °£¼ÒÈ­Çϱâ À§ÇØ Çõ½ÅÀûÀÎ µðÁöÅÐ °Ç°­ Ç÷§Æû¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. CMS Chronic Care Management ÇÁ·Î±×·¥°ú °°Àº ÀÌ´Ï¼ÅÆ¼ºê´Â Äɾî Çù¾÷À» °³¼±Çϱâ À§ÇØ 30¸¸ ¸í ÀÌ»óÀÇ ¸ÞµðÄÉ¾î ¼öÇýÀÚ¸¦ ¼º°øÀûÀ¸·Î µî·ÏÇß½À´Ï´Ù. À¯·´¿¡¼­´Â ¹ÙÀÌ¿¤°ú »ç³ëÇÇ¿Í °°Àº ´ë±â¾÷µéÀÌ 2025³â±îÁö ¸¸¼ºÁúȯ À¯º´·ü 20% °¨¼Ò¸¦ ¸ñÇ¥·Î ÇÏ´Â EUÀÇ º¸°Ç ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÈûÀÔ¾î Á¾ÇÕÀûÀÎ ÄÉ¾î ¸ðµ¨¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ºü¸£°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, Çʸ³½º¿Í °°Àº Á¶Á÷ÀÌ ¿ø°ÝÀÇ·á ¼­ºñ½º¸¦ ½ÃÀÛÇß°í, È£ÁÖ¿Í °°Àº ±¹°¡¿¡¼­´Â ÆÒµ¥¹Í ±â°£ µ¿¾È ¿ø°ÝÀÇ·á ¼­ºñ½º ÀÌ¿ëÀÌ 140% Áõ°¡Çß½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«µµ ºÎ»óÇϰí ÀÖÀ¸¸ç, ºê¶óÁúÀÇ "Saude na Hora"¿Í °°Àº ÀÌ´Ï¼ÅÆ¼ºê´Â ÀÇ·á ¼­ºñ½º¸¦ ÃæºÐÈ÷ ¹ÞÁö ¸øÇÏ´Â Áö¿ª »çȸ Àüü¿¡ Á¢±Ù °¡´ÉÇÑ ¸¸¼ºÁúȯ °ü¸® ¼­ºñ½º¸¦ Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­´Â Áö¸à½º ÇïÆ¼´Ï¾î½º(Siemens Healthineers)¿Í °°Àº ±â¾÷µéÀ» Áß½ÉÀ¸·Î ÇコÄÉ¾î ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¸¸¼ºÁúȯ °ü¸® ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¸¸¼ºÁúȯ °ü¸®ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¸¸¼ºÁúȯ °ü¸® »ê¾÷ ¿¬±¸

Á¦5Àå ¸¸¼ºÁúȯ °ü¸® ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ¸¸¼ºÁúȯ °ü¸® ½ÃÀå »óȲ

Á¦7Àå ¸¸¼ºÁúȯ °ü¸® ½ÃÀå - Ç÷§Æû À¯Çüº°

Á¦8Àå ¸¸¼ºÁúȯ °ü¸® ½ÃÀå - ¼­ºñ½º À¯Çüº°

Á¦9Àå ¸¸¼ºÁúȯ °ü¸® ½ÃÀå - Áúȯ À¯Çüº°

Á¦10Àå ¸¸¼ºÁúȯ °ü¸® ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ¸¸¼ºÁúȯ °ü¸® ½ÃÀå - Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¸¸¼ºÁúȯ °ü¸® ¾÷°è

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Chronic Disease Management Market size was valued at USD 5,109.32 Million in 2023, expanding at a CAGR of 14.90% from 2024 to 2032.

The Chronic Disease Management Market encompasses various strategies and technologies designed to improve health outcomes for individuals with chronic conditions. Chronic disease management involves the ongoing care and support of patients with long-term illnesses like diabetes, hypertension, and heart disease, with approximately 60% of adults in the U.S. living with at least one chronic condition. Rising healthcare costs, an aging population, and increasing awareness about preventive healthcare are significant factors propelling the demand for chronic disease management solutions. However, challenges such as high implementation costs, lack of skilled professionals, and patient non-compliance can hinder market growth. On the flip side, opportunities abound in the form of advancements in telemedicine, the growing integration of artificial intelligence in healthcare, and the increasing focus on personalized medicine, which can enhance the effectiveness of chronic disease management programs and improve patient adherence.

Chronic Disease Management Market- Market Dynamics

Growing Emphasis on Preventive Healthcare Fuels Expansion of the Chronic Disease Management Market

The growing emphasis on preventive healthcare is significantly driving the expansion of the Chronic Disease Management Market, as organizations and governments increasingly recognize the importance of early intervention and ongoing care. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for 7 of the 10 leading causes of death in the United States, highlighting the urgent need for effective management strategies. A study by the National Institute of Health found that lifestyle changes and preventive measures could reduce the risk of developing chronic diseases by 80%. Furthermore, initiatives like the World Health Organization's Global Action Plan aim to reduce premature mortality from non-communicable diseases by 25% by 2025, reinforcing the necessity for comprehensive chronic disease management programs that focus on prevention.

Chronic Disease Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.90% over the forecast period (2024-2032)

Based on Platform Type segmentation, Cloud-based solutions was predicted to show maximum market share in the year 2023

Based on Service Type segmentation, Care coordination was the leading type in 2023

Based on Disease Type segmentation, cardiovascular diseases was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Chronic Disease Management Market- Segmentation Analysis:

The Global Chronic Disease Management Market is segmented on the basis of Platform Type, Service Type, Disease Type, End-User, and Region.

The market is divided into three categories based on Platform Type: Web-Based Solutions, Cloud-Based Solutions, and On-Premise Solutions. Cloud-based solutions lead in popularity due to their scalability and accessibility, followed by web-based solutions that offer user-friendly interfaces for patients and providers. On-premise solutions rank third, primarily used by large healthcare organizations for data security.

The market is divided into Four categories based on Service Type: Consulting, Care Coordination, Education & Training, and Monitoring & Assessment. Care coordination services are prioritized for their critical role in patient management, followed by monitoring and assessment services that ensure ongoing evaluation. Consulting ranks third, while education and training services are essential for empowering patients.

Chronic Disease Management Market- Geographical Insights

The Chronic Disease Management Market exhibits diverse geographical dynamics, with North America leading the charge, driven by high healthcare expenditure and advanced infrastructure. In the U.S., initiatives like the CDC's National Diabetes Prevention Program have successfully reduced diabetes incidence among participants by 58%. Europe follows closely, where countries like Germany and the UK are prioritizing integrated care models to manage chronic diseases effectively, as evidenced by the NHS's commitment to diabetes management programs, which aim to improve outcomes for over 1 million patients. The Asia-Pacific region is rapidly emerging, fueled by rising awareness and a growing elderly population; for instance, Japan's health ministry has implemented a unique health management initiative targeting obesity and metabolic syndrome to combat chronic diseases. In Latin America, Brazil is working towards a more preventive healthcare model, focusing on public health campaigns to address hypertension and diabetes. Lastly, the Middle East and Africa are seeing increasing investment in healthcare technology, with initiatives aimed at enhancing chronic disease management through telehealth services and community health programs.

Chronic Disease Management Market- Competitive Landscape:

The competitive landscape of the Chronic Disease Management Market is shaped by key players across various regions, each actively working to enhance patient care. North America remains a leader, with companies like UnitedHealth Group and Cigna investing in innovative digital health platforms to streamline chronic disease management; initiatives such as the CMS Chronic Care Management program have successfully enrolled over 300,000 Medicare beneficiaries to improve care coordination. In Europe, major players like Bayer and Sanofi focus on comprehensive care models, supported by EU health initiatives aimed at reducing chronic disease prevalence by 20% by 2025. The Asia-Pacific region is witnessing rapid growth, with organizations like Philips launching telehealth services that increased by 140% in usage during the pandemic in countries like Australia. Latin America is also emerging, with initiatives such as Brazil's "Saude na Hora," which aims to provide accessible chronic disease management services across underserved communities. Meanwhile, the Middle East and Africa see increasing investments in healthcare technology, driven by firms like Siemens Healthineers, enhancing access to care and improving management strategies in the region.

Recent Developments:

In January 2024, Amazon launched a chronic condition management program in partnership with Omada Health, connecting users to services for diabetes and weight management. The initiative aims to help consumers access eligible benefits through Amazon's platform, enhancing healthcare accessibility

In February 2022, Teladoc Health launched its Chronic Care Complete program, targeting diabetes, prediabetes, and hypertension management. The initiative includes connected devices, personal health coaches, and mental health support, available through health plans or employers to enhance patient care and management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY PLATFORM TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Chronic Disease Management Market Overview

2. Executive Summary

3. Chronic Disease Management Key Market Trends

4. Chronic Disease Management Industry Study

5. Chronic Disease Management Market: COVID-19 Impact Analysis

6. Chronic Disease Management Market Landscape

7. Chronic Disease Management Market - By Platform Type

8. Chronic Disease Management Market - By Service Type

9. Chronic Disease Management Market - By Disease Type

10. Chronic Disease Management Market - By End-User

11. Chronic Disease Management Market- By Geography

12. Key Vendor Analysis- Chronic Disease Management Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â